AM 281
Tocris Bioscience, part of Bio-Techne | Catalog # 1115
Potent and selective CB1 inverse agonist
Discontinued Product
1115 has been discontinued.
View all Cannabinoid R1/CB1 Inverse Agonists products.
Key Product Details
Description
Potent and selective CB1 inverse agonist
Product Description
AM 281 is a potent, selective CB1 cannabinoid receptor antagonist/inverse agonist (Ki values are 12 and 4200 nM for CB1 and CB2 receptors respectively). Increases locomotor activity following systemic administration in vivo. Analog of SR141716A (Ki = 14 nM).Licensing Information
Sold with the permission of the University of ConnecticutProduct Specifications
Molecular Weight
557.22
Formula
C21H19Cl2IN4O2
Storage
Desiccate at +4°C
Purity
≥99% (HPLC)
Chemical Name
1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-1H-pyrazole-3-carboxamide
CAS Number
202463-68-1
PubChem ID
4302962
InChI Key
AJFFBPZYXRNAIC-UHFFFAOYSA-N
SMILES
CC1=C(N(N=C1C(=O)NN1CCOCC1)C1=C(Cl)C=C(Cl)C=C1)C1=CC=C(I)C=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 41.79 | 75 with gentle warming |
Preparing Stock Solutions
for AM 281
The following data is based on the product molecular weight 557.22
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.75 mM | 2.39 mL | 11.96 mL | 23.93 mL |
| 3.75 mM | 0.48 mL | 2.39 mL | 4.79 mL |
| 7.5 mM | 0.24 mL | 1.20 mL | 2.39 mL |
| 37.5 mM | 0.05 mL | 0.24 mL | 0.48 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Lan Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. AAPS Pharmsci. 1999 PMID: 11741201
- Gifford Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci.Lett. 1997 PMID: 9464661
- Gatley Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo. J.Neurochem. 1998 PMID: 9422389
- Cosenza Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281. Synapse 2000 PMID: 11044895
Product Specific Notices for AM 281
For research use only
Loading...
Loading...